ARTICLE SUMMARY:
Although LVADs have the potential to save the lives of many heart failure patients without other options, these devices have been plagued over the years by high rates of adverse events. Safety and efficacy are improving, as clinicians learn more about how to implant devices and care for patients, but newcomer CorWave believes the answer lies in a completely new technology.
Without left ventricular assist devices (LVADs), 250,000 patients in the US with advanced heart failure would face repeated hospitalizations and a greatly diminished quality of life during days that are numbered.
